Podcasts

For many HIV-positive women, seeing children grow to adulthood has many levels of meaning. In this podcast, a psychologist who has studied many such Moms and their kids has insights for their doctors.

CT screening for lung cancer proves as cost effective as screening for other common cancers. Listen as the head of the study speaks about the new implications for primary care.

Frequent coffee drinkers have a lower risk than those who drink little or no coffee, of death related to heart and respiratory disease, stroke, and infections.

The European Society of Cardiology just weighed in on the 3 new alternatives to warfarin for oral anticoagulation. The response is tempered enthusiasm.

High HDL levels track with low MI risk. But a Harvard medical geneticist tells why you may not be able to reduce that risk by intervening to raise them.

Whether Mom or infant takes the drugs, antiretrovirals during the first 6 months protect breast-fed infants against contracting HIV. In this interview, the lead author of the CDC-led study discusses the implications.

Anxiety is even more common than depression among people who have arthritis, a new study has shown. Here to discuss the implications for diagnosis and treatment is Eilzabeth Lin MD, a family medicine physician who is a longstanding researcher in the field of depression and pain.

Findings of the TIPS-2 study, announced at the recent 2012 World Congress of Cardiology, put the promise of the polypill-a simplified, one-size-fits-all approach to prevention of cardiovascular morbidity-back on the table for international discussion. Here, Dr Christopher Cannon puts the TIPS-2 results in perspective.

Are these findings another green light for dark chocolate? Some experts say “yes” as they also point to a recommended upper daily “dose.” What does this new research add to the current data on the health benefits of the flavinoid-rich sweet? Drs Payal Kohli and Christopher Cannon discuss study results and what you should tell your patients.

There's no need to abandon abacavir as an option for AIDS treatment fearing adverse effects. This podcast features a new guideline that shows how to use easily ordered genetic tests to judge who can take the drug safely.